Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 699
Aptamer sequence: GCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTGGGGAGGTGCGGTTGC
Target unique ID: 7955
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_656 Rd29C33-P1 Molecule Melamine 0.61 μM Cyanuric acid, Ammeline, Ammelide 27171923
Structure information of aptamer
Aptamer Sequence: GCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTGGGGAGGTGCGGTTGC
The optimal secondary structure in dot-bracket notation: ((((.((.((((((.((((((.................))))))..))).))).))...))))......
The centroid secondary structure in dot-bracket notation: ((((.((.((((((..(((((.................)))))...))).))).))...))))......
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_656 Description Rd29C33-P1
Aptamer chemistry DNA Length 69 nt
GC content 60.9% Molecular weight 21,538.71 Da
Molarity of 1 μg/μl solution 46.43 μM Number of G-quadruplexes 2
G-Score 19 Function Target detection
Sequence GCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTGGGGAGGTGCGGTTGC
Applications Detection of melamine
Target information
Type Detail Type Detail
PubChem ID 7955 Molecular name Melamine
Molecular formula C3H6N6 Molecular weight 126.12
IUPAC name 1,3,5-triazine-2,4,6-triamine InChIKey JDSHMPZPIAZGSV-UHFFFAOYSA-N
LogP -1.382 Topological polar surface area 116.73
Hydrogen bond acceptor 6 Hydrogen bond donor 3

Synonym(s):
MELAMINE; 1,3,5-Triazine-2,4,6-triamine; 108-78-1; Cyanuramide; Cyanurotriamide; Cyanurotriamine; Isomelamine; Theoharn; Teoharn; Triaminotriazine; Cyanuric triamide; Hicophor PR; s-Triazinetriamine; Aero; Yukamelamine; Pluragard; Cymel; 2,4,6-Triamino-1,3,5-triazine; Virset 656-4; 2,4,6-Triamino-s-triazine; Spinflam ML 94M; 2,4,6-Triaminotriazine; Pluragard C 133; ADK Stab ZS 27; Mark ZS 27; DG 002 (amine); Melamine Monomer; NCI-C50715; Cyanurtriamide; s-Triazine, 2,4,6-triamino-; 1,3,5-Triazine-2,4,6(1H,3H,5H)-triimine; ZS 27; UNII-N3GP2YSD88; NSC 2130; DG 002; sym-Triaminotriazine; DTXSID6020802; N3GP2YSD88; CHEBI:27915; melamin; s-triaminotriazine; CCRIS 373; HSDB 2648; EINECS 203-615-4; BRN 0124341; 2,4,6-triamino sym-triazine; AI3-14883; AX2; Melamine, 99%; 2,6-Triaminotriazine; CYMEL (Salt/Mix); Metformin EP impurity D; 2,4,6-Triamino-1,3,5-triazine Monomer; DSSTox_CID_802; 2,6-Triamino-s-triazine; Melamine-13C3,15N3; 1,3,5-triazine-2,4,6(1H,3H,5H)triimine; EC 203-615-4; s-Triazine,4,6-triamino-; DSSTox_RID_75795; DSSTox_GSID_20802; SCHEMBL25853; Melamine, analytical standard; 4-26-00-01253 (Beilstein Handbook Reference); BIDD:ER0287; CHEMBL1231106; SCHEMBL12192199; 1,5-Triazine-2,4,6-triamine; 2,6-Triamino-1,3,5-triazine; NSC2130; NSC8152; Melamine 100 microg/mL in Water; ZINC897751; HY-Y1117; NSC-2130; NSC-8152; WLN: T6N CN ENJ BZ DZ FZ; Tox21_200503; 1,3,5-triazinane-2,4,6-triimine; BBL000010; MFCD00006055; s9212; STK378738; [1,3,5]triazine-2,4,6-triamine; 1,3, 5-Triazine-2,4,6-triamine; 2,4, 6-Triamino-1,3,5-triazine; AKOS005448714; CCG-266105; MCULE-1467355510; NCGC00164014-01; NCGC00164014-02; NCGC00258057-01; 1246816-14-7; 2,4,6-triamino-1,3,5-triazine;melamine;1,3,5-triazine-2,4,6-triamine;[1,3,5]triazine-2,4,6-triamine;s-triazine, 4,6-diamino-1,2-dihydro-2-imino-;2,4,6-triamino-1,3,5-triazine melamine 1,3,5-triazine-2,4,6-triamine [1,3,5]triazine-2,4,6-triamine s-triazine, 4,6-diamino-1,2-dihydro-2-imino-; AC-34715; CAS-108-78-1; VS-00405; 1,3,5-Triazine-2,4,6-triamine monomer; Melamine 1.0 mg/ml in Dimethyl Sulfoxide; CS-0016866; FT-0609833; FT-0670982; FT-0670983; Melamine; 1,3,5-Triazine-2,4,6-triamine; T0337; 1,3,5-Triazine-2,4,6-triamine (Melamine); 1,5-Triazine-2,4,6(1H,3H,5H)-triimine; Melamine 100 microg/mL in Acetonitrile/Water; 4,6-Diamino-1,2-dihydro-2-imino-S-Triazine; C08737; E76265; 78403-EP2270101A1; 78403-EP2270113A1; 78403-EP2272849A1; 78403-EP2272935A1; 78403-EP2276751A1; 78403-EP2289896A1; 78403-EP2298828A1; 78403-EP2301924A1; 78403-EP2301983A1; 78403-EP2308856A1; 78403-EP2374895A1; s-Triazine, 4,6-diamino-1,2-dihydro-2-imino-; Q212553; J-002191; 1,3,5-Triazine-2,4,6-triamine (ACD/Name 4.0); Melamine, >=95.0% (HPLC), pharmaceutical impurity standard; Melamine, United States Pharmacopeia (USP) Reference Standard; N,N',N''-Tri-2-pyridinyl-1,3,5-triazine-2,4,6-triamine; Melamine, Pharmaceutical Secondary Standard; Certified Reference Material; 5432-64-4

Activity data

No relevant experimental diagram

 Interaction ID 699
Target type Molecule
Target unique ID 7955
Activity 0.61 μM
Binding Conditions/Buffer

Cyanuric acid, Ammeline, Ammelide
Assay

N/A
PubMed ID 27171923
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_657 DNA CCTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTGGGGAGGTGCGGTTGC 78.41%
Apta_654 DNA GCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTG 78.26%
Apta_650 DNA GCACACCGATGGCGGTCCTGTTTAGGGGGTGTGCGTGGGGAGGTGCGGTTGC 75.36%
Apta_732 DNA AAGGAGCAGCGTGGAGGATAGCTGTCATCGGCTTATGTGCTTTCCAGGGTCCGTGCTGTCCGTTGTTAGGGTGTGTCGTCGTGGT 55.29%
Apta_223 DNA CATTGAGATAGCTAGTTGTAGCTGCGTCATAGGCTGGGTTGGGTCTAGTGGTTGGGTGTG 55.07%
Apta_942 DNA AGTGGGTAAGGTCTGGTGGATTGTGGACGGGGGGCGGGGCAGTGGCTTGA 55.07%
Apta_800 DNA AAGGAGCAGCGTGGAGGATATACACCGTCATCAGAGGGAGCATCTCTAGTCAGGACTGTGATGAATTAGGGTGTGTCGTCGTGGT 54.12%
Apta_784 DNA ATCCAGAGTGACGCAGCATTTTGACGCTTTATCCTTTTCTTATGGCGGGATAGTTTCGTGGACACGGTGGCTTAGT 53.95%
Apta_842 DNA TGAGCCCAAGCCCTGGTATGTGTGGGGTCCTGGATTATGTTTAGCGTCTTTCGCAGTGGGGGCAGGTCTACTTTGGGATC 53.75%
Apta_508 DNA GCGGGCGATCGGCGGGGGGTGCGTGCGCTCTGTGCCAGGGGGTGGGACAGATCATATGGGGGTGCT 53.62%
Apta_570 DNA GGCAAGATGTGCCCAGAACAGTTGCTTGTATGGTGGGGAGCGTCCATATTGGCTTAAAC 53.62%
Apta_649 DNA GCACACCGATGGCGGTCCTGTTTAGGGGGTGTGCGTG 53.62%
Apta_729 DNA AACACCGTGGAGGATAGTTCGGTGGCTGTTCAGGGTCTCCTCCCGGTG 53.62%
Apta_738 DNA ATCGTCTGCTCCGTCCAATACCTGCATATACACTTTGCATGTGGTTTGGTGTGAGGTCGTGC 53.62%
Apta_655 DNA CCTGCACCTCGTCCAGCATGCACACCGATGGCGGTCCTGTTTTACGGTAGCTTATATGCAGGGGGTGTGCGTG 53.42%
Apta_1175 DNA ATGAGAGCGTCGGTGTGGTATCCTACTCGTGATATCGGTGTTTATGGTGTCTGTCTTCATGTAGGAGGGTGCGGAAGTA 53.16%
Apta_773 DNA GAATTCAGTCGGACAGCGGTGGTGCTTGTGTATGGGGGTGGTTGGTGGGTTTTATGCTGCTGGATGGACGAATATCGTCTCCC 53.01%
Apta_731 DNA AAGGAGCAGCGTGGAGGATACTCTAATTGCCGTATAAGGTCAGGGGGTTGGTTGGTTCCTAGTGCTTAGGGTGTGTCGTCGTGGT 52.94%
Apta_173 DNA AGCAGCACAGAGGTCAGATGGCAGGTTTCGACGTACAATGCTATGGAGGCTTTATGATCGCCTATGCGTGCTACCGTGAA 52.50%
Apta_236 DNA AGCAGCACAGAGGTCAGATGAGATGGTTGACCGGTTGATGTGATTAAGGAGACGTCGATTCCTATGCGTGCTACCGTGAA 52.50%

ABOUT

AptaDB is an online database we developed to integrate comprehensive information about aptamer.
The detail of this database is described here:

HELP CENTER

>Contact us
>LMMD Group
>School of Pharmacy

DEV TOOL
Page last updated at 2022-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 43982
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.